Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma
/in Dendritic Cells, International Publications, Malignant LymphomaAntitumor vaccines, immunotherapy and the immunological constant of rejection
/in Dendritic Cells, International PublicationsConditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine
/in Dendritic Cells, International PublicationsTumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens
/in Dendritic Cells, International Publications, Prostate CancerVaccination strategies in patients with renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsA combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic CancerDCVax-Brain and DC vaccines in the treatment of GBM
/in Dendritic Cells, Glioblastoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer